Acute Intermittent Porphyria:

Slides:

Advertisements

Similar presentations

Human hepatocytes The liver fulfills many vital processes in mammals. It is the central organ of energy metabolism, biotransformation of xenobiotics, and.

Advertisements

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Incorporating New Therapies in IBS-C

A Common Clinical Challenge: Neonatal Jaundice Is it Physiologic or Pathologic?

Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.

Chronic Hepatitis C Virus Infection

Acute Heart Failure.

Tailoring Statin Therapy in Women

Fundamental Concepts in the Diagnosis of Advanced NSCLC

Challenges in the Diagnosis of MS: Physician and Nurse Perspectives

Improving Management of Rosacea From Therapeutics to Routine Skin Care

Ask the Onychomycosis Expert, Part 2

Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.

Unmet Needs in the Secondary Prevention in ACS

Update on Clostridium difficile Infection

Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.

SGLT2 Inhibitors in the Modern Era: Why and Where?

Before and After: Patient Cases in Onychomycosis

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

A Call to Action on Cryptogenic Stroke

Panelists. Secondary Prevention of Acute Ischemic Stroke: Can We Improve Outcomes?

Can Pregnancy Stop Cyclical Attacks of Porphyria?

Follow-Up of the Patient After PE

Updates in Neuronal Ceroid Lipofuscinosis

Best Practices in Metastatic Colorectal Cancer

Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.

Seizures in the Elderly: Treatment and Special Considerations

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.

Remote Patient Management:

Evaluating New Therapies in HF

A Roadmap to Diagnosing the Next Patient With Hereditary Angioedema

Panelists. Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?

Multidisciplinary Management of Hyperkalemia:

Hyperammonemia: Best Practices for Diagnosis and Treatment

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

acute, chronic, or acute on chronic.

Revisiting the Pharmacoeconomics of HF

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

When to Start and What to Use

Hepatitis C: After the Diagnosis

Patient-Centered Management in BRAF-Positive Metastatic Melanoma

Clinical Issues in AIP:

Updates in Neuronal Ceroid Lipofuscinosis

A Guideline-Based Approach to HCV Care

Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.

Statins, Obesity, and Hyperlipidemia

Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Communicating With Your Patients About Major Depressive Disorder

Current Controversies and Advances in Hepatorenal Syndrome

Treating Atypical Hemolytic Uremic Syndrome A Case Discussion

A Multidisciplinary Perspective on the Management of Hypoparathyroidism.

Assessing the Burden of Hyperkalemia

The Role of Measurable Residual Disease in AML

Disease Burden of VTE Phases of VTE Treatment.

New Lipid-Lowering Guidelines

Educational Objectives

Contemporary Considerations in Biomarker-Guided Therapy

So Many Guidelines, So Little Time:

AMD Therapy: Where Are We Now and Where Are We Going?

What Is Acute Intermittent Porphyria? Why AIP Is Often Undiagnosed or Misdiagnosed.

Assessing the Burden of Hyperkalemia

VTE Treatment and Secondary Prevention VTE Treatment Trials Initial Dosing.

Targeting Apoptosis in AML

Advances in Alport Syndrome

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer

Statin Therapy in Patients With Insulin Resistance

Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice

Navigating the Journey

Presentation transcript:

Acute Intermittent Porphyria:

Acute Intermittent Porphyria

Acute Intermittent Porphyria Often Undiagnosed or Misdiagnosed

Multisystem Involvement

Dr. Kehrberg's Experience Undiagnosed and Untreated

Dr. Kehrberg's Experience (cont)

AIP-specific Therapy in Naive Patient Without Diagnosis

Testing for AIP

Timely Diagnosis of AIP is Critical

AIP Triggers

Acute Management of AIP Cornerstones

Dr Kehrberg's Advice to ED Physicians: Think Porphyria

Mechanisms of Action Glucose and Hemin

Long-term Management of AIP

Liver Transplantation for AIP Gene Therapy At Its Best

Future siRNAs

Preventing Recurrent Acute Porphyric Attacks

Abbreviations

References

References (cont)